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Background: Early oral squamous cell carcinoma (EOSCC) represents about 90% of the oral cancers
especially in older males. The etiology is multifactorial, strongly related to tobacco and alcohol abuse, but
also infective agents, Human papillomaviruses (HPV16-18), genetic factors and pre-neoplastic lesions
seem to be implicated. There is no consensus in the literature for the treatment of early squamous cell
carcinoma of the tongue (stages IeII); both an elective neck dissection policy and a watchful-waiting
policy have their proponents in the different centers.
Methods: The records of 127 patients with EOSCC of the tongue treated in our Department between 2007
and 2011, with cN0 neck staging, who underwent resection of the primary tumor with or without
elective neck dissection, were reviewed.
Results: We divided the patients into two groups, in Group 1 the 66 patients who received an elective
neck dissection 30 days later from the primary surgery have been included, and in Group 2 the 61 pa-
tients undergoing “watchful waiting” observation for the development of nodal metastases have been
collected.
Statistical calculations were performed using Chi-square and t student test.
Conclusions: A signiﬁcant difference was found between the two groups as concerns tumor stage and
pathologic tumor classiﬁcation (p < 0.001). No signiﬁcant differences were present between the two
groups as concerns mean follow up (P ¼ 0.2), relapse rate (p ¼ 0.3) and relapse-free survival time
(p ¼ 0.2).
In T1 stage tumors with depth of inﬁltration 4 mm, or low grade (G1-G2), the “watchful waiting”
strategy for cervical metastases is appropriate, given the low regional recurrence rate (15%) and overall
survival of 100%.
In case of T2 lesions with depth of inﬁltration 4 mm or high grade (G3) we prefer to perform the
elective neck dissection, with 13% of local recurrence and 100% of survival at 6 years.
© 2016 Elsevier Ltd. All rights reserved.1. Introduction
Early oral squamous cell carcinoma (EOSCC) represents about
90% of the oral cancers, especially in older males. It is mainly
observed on the lips and on the tongue. The spread is local through
muscle and bone, and metastasizes initially to the anterior cervical
lymph nodes and later to the liver and skeleton [1]. The etiology is
multifactorial, strongly related to tobacco and alcohol abuse [2], but.
onavolonta).also infective agents, Human papillomaviruses (HPV16-18) [3],
genetic factors and pre-neoplastic lesions seem to be implicated.
The most important risk factor is tobacco because of an inter-
action that occurs between redox-active metals in saliva, and the
low reactive free radicals in cigarette smoke [3].
There is no consensus in the literature for the treatment of early
squamous cell carcinoma of the tongue (stages IeII); both an
elective neck dissection policy and a watchful-waiting policy have
their proponents in the different centers. Jesse et al. [4] have not
found any survival beneﬁt to choose the elective neck dissection,
but others studies have demonstrated that the watchful-waiting
patients had more regional recurrences and extremely poor
Table 1
Baseline patient characteristics by Elective Neck Dissection policy group (Group 1).
All patients (n ¼ 66)
Sex
Male 37 (56%)
Female 29 (44%)
Median age 52.4 ± 16.0 years (range, 28e87)
Follow up 41.6 ± 13.0 months (range, 10e58)
Depth of inﬁltration
3(mm) 20 (30,3%)
>3  4(mm) 26 (39,3%)
>4(mm) 20 (30,3%)
Clinical Tumor stage
cT1 12 (18.2%)
cT2 54 (81.8%)
Clinical Nodal stage
cN0 66 (100%)
cN1 0
Tumor grade
1 4 (6%)
2 11 (16,7%)
3 51 (77,3%)
Clinical distant metastases none
Pathological Tumor stage
pT1 14 (21,2%)
pT2 52 (78,8%)
Pathological Nodal Stage
pN0 58 (87,8%)
pN1 8 (12,2%)
Extracapsular spread None
Vascular invasion 2 (3%)
Perineural invasion 2 (3%)
Margins positive 5 (7,6%)
 Second line treatment
Surgical radicalization 3 (4,5%)
Radiation Theraphy 2 (3%)
Tumor recurrence 8 (21,2%)
 Second line treatment
Surgical treatment 8 (21,2%)
Overall relapse-free survival 37.9 ± 15.0 months
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During the last ﬁve years, we have analyzed all the data about
the patients affected by head and neck tumors [7,8].
In this study we report our experience in the treatment of 127
patients affected by squamous cell carcinoma of the tongue.
2. Patients and methods
Among 350 cases of oral squamous cell carcinoma of the tongue
treated in our Department between 2007 and 2011, the data of 127
patients affected by early oral squamous cell carcinoma of the
tongue, with cN0 neck, who underwent resection of the primary
tumor, with or without elective neck dissection, were reviewed in
order to make a comparison between these different strategies. We
included in our study patients with early squamous cell carcinoma
of the tongue in stage cTNM: T1-T2 N0 M0. The data we have
included are: tumor's size (T), tumor's thickness, the vascular and
perineural invasion, the grading, the extracapsular spread, the type
of treatment, the pTNM, the recurrence, and outcome. Exclusion
criteria were: patients with different histological type of tumors or
other localization in the oral cavity. Another exclusion criteria was
the cTNM > T2 or the nodal involvement. All patients were staged
using the 7th American Joint Committee on Cancer TNM classiﬁ-
cation and staging of oral cancer.
According to our protocol, all patients underwent echography of
the neck, routine Computed Tomography (CT) or Magnetic Reso-
nance (MR) of the head and neck and total body Pet-CT; further-
more, biopsy of the lesion.
All patients underwent surgical excision of the primary tumor.
We divided the patients into two groups, in Group 1 the 66 patients
who received an elective neck dissection (Level I-III) 30 days later
from the primary surgery have been collected, and in Group 2 the
61 patients undergoing watchful waiting observation for the
development of nodal metastases have been included.
We evaluated the tumor depth and grading, the vascular and
perineural invasion; in all the cases the depth of the tumor invasion
was not exceeding 4e5 mm. We decided to perform elective neck
dissection in patients with tumor thickness 4 mm or G3 tumor
grade.
Statistical calculations were performed using the Statistical
Package for Social Sciences (version 17.0, SPSS Inc., Chicago, IL,
USA). Chi-square test was used in order to compare tumor stage,
pathologic tumor classiﬁcation and relapse rate between the two
Groups. Student’ t-test was used to compare mean follow-up and
overall relapse-free survival between the two groups. Survival
curves were calculated using the KaplaneMeier method. The sig-
niﬁcance level for all analyses was set at p < 0.05.
3. Results
All 127 patients (68 females, 59 males, mean age 59.4 ± 14.2
years) included in the study, received biopsy before surgery. As
mentioned before, in the Group 1, 66 patients (29 females and 37
males, mean age 52.4 ± 16.0 years) were included. Mean follow-up
was 41.6 ± 13.0 months (range, 10e58).
Among them, 12 patients (18.2%) had cT1 stage tumor, and 54
patients (81.8%) had a cT2 stage tumor. Fourteen cases (21,2%) had
pathologic tumor classiﬁcation (pT1), and 52 cases (78,8%) showed
a pathologic tumor classiﬁcation (pT2). In 2 patients (3%) vascular
and perineural invasion was present. Eight patients (12,2%) had
positive pathologic nodes (pNþ) without extracapsular spread and
58 cases had pN0 (87,8%). Margins were positive in 5 cases (7,6%). In
these cases, the second line treatment was surgical radicalization in
3 of them (4,5%), and radiation therapy (RT) in the other two pa-
tients (3%) previously treated by reconstructive surgery. In case ofvascular and perineural invasion radiation therapy was performed.
No patient developed clinical distant metastases (cM0). Eight pa-
tients (12,2%) had a tumor recurrence (range of relapse: from 13 to
28 months) that required another surgical treatment. Overall
relapse-free survival was 37.9 ± 15.0 months (Table 1).
In the Group 2, 61 patients (39 females and 22 males, mean age
60.4 ± 11.9 years) were included. Mean follow-up was 38.0 ± 16.7
(range, 9e66) months.
Among them, 50 patients (82%) had a cT1 stage tumor, 11 pa-
tients (18%) had a cT2 stage tumor. Forty-ﬁve patients (73,7%) had
pT1, and 16 patients (26,3%) had pT2. Sixty-one patients (100%) had
negative clinical nodes (cN0).
Margins were positive in 3 cases (4,9%); In case of positive
margins, the second line treatment was surgical radicalization. Five
patients (8,2%) had a local recurrence (range of relapse: from 12 to
18 months) that required another surgical treatment. Overall
relapse-free survival was 34.2 ± 16.4 months (Table 2).
A signiﬁcant difference was found between the two groups
regarding the tumor stage and the pathologic tumor classiﬁcation
(p < 0.001). No signiﬁcant differences were present between the
two groups as concerns mean follow-up (P ¼ 0.2), relapse rate
(p ¼ 0.3), and relapse-free survival time (p ¼ 0.2) (Fig. 1).
4. Discussion
The goal of treatment for early oral squamous cell carcinoma of
the tongue is to ensure a complete excision of the primary tumor
with at least a 2-cm margin of clinically normal tissue during the
ﬁrst surgical procedure.
Table 2
Baseline patient characteristics by Watchful-waiting policy group (Group 2).
All patients (n¼61)
Sex
Male 22 (%)
Female 39 (%)
Median age 60.4 ± 11.9 (range, 39e82) years
Follow up 38.0 ± 16.7 (range, 9e66) months
Depth of inﬁltration
3(mm) 52 (85,2%)
>3  4(mm) 9 (14,8%)
>4(mm) e
Clinical Tumor stage
cT1 50 (82%)
cT2 11 (18%)
Clinical Nodal stage
cN0 61 (100%)
cN1 e
Tumor grade
1 37 (60,7%)
2 24 (39,3%)
3 e
Clinical distant metastases none
Pathological Tumor stage
pT1 45 (73,7%)
pT2 16 (26,3%)
Margins positive 3 (4,9%)
 Second line treatment 3 (4,9%)
Surgical radicalization
Tumor recurrence 5 (8,2%)
 Second line treatment
Surgical treatment 5 (8,2%)
Overall relapse-free survival 34.2 ± 16.4 months
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aggressive behavior and are associated to a poor prognosis [6].
Many factors, such as tumor growth type, size, differentiation,
mode of invasion, mitotic activity, microvascular invasion, and
histological grade of malignancy have been reported to be risk
factors for the development of cervical lymph node metastasis that
indicate a poor prognosis [9e11].
We believe, according to the literature, that the tumor thickness
is a major predictive factor for cervical lymph node metastasis and
is related with survival and local recurrence [12e14].Fig. 1. Cumulative survival until relapse in the two groups (Group 1, Elective neck
dissection; Group 2, watchful waiting observation for development of nodal
metastases).The incidence of lymph node metastasis increased when the
tumor depth exceeded 4 mm. If at least 1 node has clinical signs of
invasion, a reasonable presumption is that others may be involved,
and must be removed by elective neck dissection (Level I-III).
The surgical treatment of the cN0 neck in oral squamous cell
carcinoma is still controversial, because of its uncertainty on the
patient prognosis.
In the literature, the incidence of occult nodal metastasis has
been reported to be 30%e40% [14e16].
On the basis of the high incidence of occult nodal metastasis
reported in the literature, elective neck dissection has been sug-
gested as primary treatment of T1eT2 tongue squamous cell cancer
with cN0 neck [17e20].
With increasing sensitivity and speciﬁcity of imaging modality
to detect early nodal metastasis, the negative predictive value of
imaging to exclude occult nodal metastasis has much improved.
Thus, the watchful waiting policy has been advocated again. Tsang
et al. [21] demonstrated that salvage neck dissection may not be
effective for controlling nodal recurrence in T2 tumors of the oral
cavity, and watchful waiting policy should only be adopted for
patients with T1 disease, tumor thickness  4 mm, grading  G2,
and who are able to undergo close follow-up. The elective treat-
ment of the neck lymph nodes, either in the form of elective neck
dissection or radiotherapy, should seriously be considered in pa-
tients with T2 tumors of the oral cavity, tumor thickness >4 mm or
grading > G2.
Yuen showed that elective neck dissectionmarkedly reduces the
nodal recurrence rate [5]. He described in 2009 a survival rate of
89% at 5 years after elective neck dissection, versus 87% of survival
in patients who underwent awatchful-waiting policy, after surgical
removal of the tumor. Other studies have also shown that the
elective neck dissection improves survival rates in patients with
early tongue cancer and other oral cavity cancers [19,20,22e24].
Although some Authors consider the elective neck dissection in
early tongue cancer a staging procedure that provides indication for
adjuvant treatment [25,26]. Yu et al. [27] in 2006 reported a sur-
vival rate of 5 years in 100% after elective neck dissection, versus
68,7% of survival in patients that were only observed.
Different results were found by Yuen et al. who reported a
survival rate of 5 years in 66% of patients after the elective neck
dissection, versus 63% of survival in patients that were only
observed [28].
Other studies have shown that the elective neck dissection alone
has a therapeutic effect in the early treatment of nodal diseases at
levels I, II and III [26,29].
In effect, the elective neck dissection has both, therapeutic ef-
fects and guides for further adjuvant treatment. On the contrary,
salvage surgery of nodal recurrence in head and neck cancer has
been shown to be only moderately effective in controlling the
disease, with a 5-year tumor-free survival rate of 32% [30].
All the cases of nodal recurrence in this study occurred less than
18 months after the initial operation for the tongue cancer. These
nodal recurrences are probably due to micrometastasis already
present in the lymph nodes that failed clinical detection. By im-
provements in imaging technologies, a more accurate preoperative
nodal staging is now possible without resorting to pathologic
staging. Ultrasound-guided ﬁne-needle aspiration cytology study,
can achieve high positive and negative predictive values [31].
Thus, we can now more conﬁdently consider that cN0 neck is
genuinely negative for lymph node metastasis.
Melkane, and more recently Sagheb in a prospective study,
suggest that the sentinel node biopsy appears to be an excellent
staging method in early oral cancers and can guide the surgeon's
strategy [32,33].
In conclusion in our opinion, for tumors of the tongue at T1
G.D. Orabona et al. / Surgical Oncology 25 (2016) 401e404404stage, with thickness 4 mm, grading  G2, the watchful-waiting
strategy for cervical metastases is appropriate, given the low
regional recurrence rate (15%) and overall survival of 100%. In case
of T2 lesion, tumor thickness >4 mm or grading > G2, we prefer to
perform the elective neck dissection, with 13% of local recurrence
and 100% of survival at 6 years. Furthermore in case of vascular or
perineural invasion we strongly recommend radiation therapy.
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Synopsis
In this paper, we report on 127 cases of early oral squamous cell
carcinoma of the tongue. This is signiﬁcant because there is not
general consensus about the treatment of the tumor in this stage.
The paper should be of interest to readers in the areas of Maxillo-
Facial surgery and head and neck surgery.
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